BWL
TTNP

Bogart Wealth LLC’s Titan Pharmaceuticals TTNP Stock Holding History

Bogart Wealth LLC’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 2010
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 1824

Other funds holding TTNP

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $265M AUM 30.15% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Bogart Wealth LLC's TTNP Position: Q2 2026 in Review

Bogart Wealth LLC held its Titan Pharmaceuticals (TTNP) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2010.

Bogart Wealth LLC first reported a position in TTNP in Q1 2026 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold TTNP as of Q2 2026.

  • Bogart Wealth LLC held 1 share of Titan Pharmaceuticals worth $1 as of Q2 2026.
  • Bogart Wealth LLC left its Titan Pharmaceuticals share count unchanged in Q2 2026.
  • Titan Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #2010 holding.
  • Bogart Wealth LLC first reported a position in Titan Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 5 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.